People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Aliyah Lofton Promising review: "As embarrassing as it is to admit, I used this in the car on a road trip. I didn't know ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...

Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.

Munson Healthcare is taking steps to make sure Narcan is accessible to everyone.It's partnering with Harm Reduction Michigan ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Rep. Mike Collins (R-Ga.) heavily criticized statements made by the Right Rev. Mariann Budde on Tuesday at the inaugural ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration has approved a nasal spray to treat depression—the first-ever stand-alone medication ...